کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1429742 | 987180 | 2011 | 6 صفحه PDF | دانلود رایگان |
Metastable β-Ti alloys are becoming attractive materials for structural biomedical applications due to the low modulus of elasticity that these alloys can offer. Stabilizing the β-phase and suppressing the formation of other phases such as martensite through careful composition control and processing, are essential to achieving a low modulus. Traditional manufacturing processes such as investment casting may be a suitable production pathway for these new components but a concern is that the compositional fluctuations that occur during solidification may affect the stability of the β-phase. This work characterises the segregation of solute in the Ti–25Nb–3Mo–3Zr–2Sn alloy and discusses the practical implications of this segregation in biomedical components produced via solidification routes.
► We model and characterise the solute redistribution during solidification of a metastable β-titanium alloy.
► We discuss the implications of solute redistribution on phase stability.
► We discuss important processing considerations for biomedical β-titanium alloys produced via a solidification route.
Journal: Materials Science and Engineering: C - Volume 31, Issue 7, 10 October 2011, Pages 1520–1525